BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis. 2015;30:159-171. [PMID: 25376337 DOI: 10.1007/s00384-014-2063-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Liu P, Song Y, Shakoor K, Peng C, Liu S. The pros and cons of the PCC staging system to guide surgical resectability and prognosis. J Cancer 2022;13:3444-51. [PMID: 36313036 DOI: 10.7150/jca.76696] [Reference Citation Analysis]
2 Xiong F, Peng F, Li X, Chen Y. Preliminary comparison of total laparoscopic and open radical resection for hepatic hilar cholangiocarcinoma a single center cohort study. Asian Journal of Surgery 2022. [DOI: 10.1016/j.asjsur.2022.07.158] [Reference Citation Analysis]
3 Lee M, Jung H, Cho YJ, Yoon W, Han Y, Kim H, Kwon W, Jang J. Oncological outcome of proximal and middle extrahepatic bile duct cancer according to surgical extent (Is hilar resection oncologically acceptable in proximal and middle extrahepatic bile duct cancer?). HPB 2022. [DOI: 10.1016/j.hpb.2022.09.009] [Reference Citation Analysis]
4 He Y, Huang W, Ren Q, Li J, Yang F, Deng C, Li L, Peng X, Tang Y, Zheng L, Huang X, Li Y. Comparison of Efficacy and Safety Between Laparoscopic and Open Radical Resection for Hilar Cholangiocarcinoma—A Propensity Score-Matching Analysis. Front Oncol 2022;12:1004974. [DOI: 10.3389/fonc.2022.1004974] [Reference Citation Analysis]
5 Alshumrani GA, Al-Khani AM. Percutaneous Y-shape reconstructive biliary stenting in Klatskin cholangiocarcinoma through a single left-sided entry. Ann Saudi Med 2022;42:64-7. [PMID: 35112594 DOI: 10.5144/0256-4947.2022.64] [Reference Citation Analysis]
6 Li X, Yan L, Xue H. Serum epithelial membrane protein 1 serves as a feasible biomarker in extrahepatic cholangiocarcinoma. Int J Biol Markers 2021;36:33-9. [PMID: 34569869 DOI: 10.1177/17246008211035142] [Reference Citation Analysis]
7 Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
8 Xu X, Yang L, Chen W, He M. Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes. J Int Med Res 2021;49:3000605211008336. [PMID: 33983055 DOI: 10.1177/03000605211008336] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wu W, Cheng Q, Chen J, Chen D, Feng X, Wu J. Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis. World J Surg Oncol 2021;19:107. [PMID: 33838682 DOI: 10.1186/s12957-021-02213-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Tang W, Qiu JG, Deng X, Liu SS, Cheng L, Liu JR, Du CY. Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness. PLoS One 2021;16:e0248534. [PMID: 33705481 DOI: 10.1371/journal.pone.0248534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Liu F, Hu HJ, Ma WJ, Wang JK, Ran CD, Regmi P, Li FY. Is radical resection of hilar cholangiocarcinoma plus partial resection of pancreatic head justified for advanced hilar cholangiocarcinoma? ANZ J Surg. 2020;90:1666-1670. [PMID: 32452116 DOI: 10.1111/ans.15955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Ma WJ, Li FY, Cheng NS. When Should Hepatectomy be Performed for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma? Ann Surg Oncol 2020;27:926-7. [PMID: 32394300 DOI: 10.1245/s10434-020-08560-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang W, Fei Y, Liu J, Yu T, Tang J, Wei F. Laparoscopic surgery and robotic surgery for hilar cholangiocarcinoma: an updated systematic review. ANZ J Surg 2021;91:42-8. [PMID: 32395906 DOI: 10.1111/ans.15948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Kovalenko YA, Zharikov YO, Konchina NA, Gurmikov BN, Marinova LA, Zhao AV. Perihilar cholangiocarcinoma: A different concept for radical resection. Surg Oncol 2020;33:270-5. [PMID: 32561092 DOI: 10.1016/j.suronc.2020.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Jo HS, Kim DS, Yu YD, Kang WH, Yoon KC. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study. World J Surg Oncol 2020;18:3. [PMID: 31901228 DOI: 10.1186/s12957-019-1779-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Abdullah Madkhali A, Al-alem F. Distal Cholangiocarcinoma. Bile Duct Cancer 2019. [DOI: 10.5772/intechopen.84625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Li QJ, Zhou ZG, Lin XJ, Lao XM, Cui BK, Li SP. Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma. BMC Gastroenterol 2019;19:99. [PMID: 31221103 DOI: 10.1186/s12876-019-1012-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Huang H, Wan X, Bai Y, Bian J, Xiong J, Xu Y, Sang X, Zhao H. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma. Cancer Manag Res. 2019;11:5157-5162. [PMID: 31239770 DOI: 10.2147/cmar.s192532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
19 Ma WJ, Wu ZR, Hu HJ, Wang JK, Yin CH, Shi YJ, Li FY, Cheng NS. Extended Lymphadenectomy Versus Regional Lymphadenectomy in Resectable Hilar Cholangiocarcinoma. J Gastrointest Surg. 2019;Online ahead of print. [PMID: 31147975 DOI: 10.1007/s11605-019-04244-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kovalenko YA, Vishnevsky VA, Chzhao AV, Zharikov YO. [New criteria of radical surgery and long-term outcomes of hilar cholangiocarcinoma management]. Khirurgiia (Mosk) 2018;:4-11. [PMID: 30113586 DOI: 10.17116/hirurgia201884] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Liu F, Hu H, Regmi P, Li F. Hilar cholangiocarcinoma with distal bile duct involvement: Is hepatopancreatoduodenectomy always required? Clinics and Research in Hepatology and Gastroenterology 2018;42:610-1. [DOI: 10.1016/j.clinre.2018.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Ma WJ, Li FY, Cheng NS. Does caudate lobe resection really not improve the survival and outcomes in patients with hilar cholangiocarcinoma? Surgery 2019;166:947-8. [PMID: 30391010 DOI: 10.1016/j.surg.2018.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Ma WJ, Wu ZR, Shrestha A, Yang Q, Hu HJ, Wang JK, Liu F, Zhou RX, Li QS, Li FY. Effectiveness of additional resection of the invasive cancer-positive proximal bile duct margin in cases of hilar cholangiocarcinoma. Hepatobiliary Surg Nutr 2018;7:251-69. [PMID: 30221153 DOI: 10.21037/hbsn.2018.03.14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
24 Li X, Zhang Y, Zhang Y. 18F-FDG PET/CT may be a suitable method for preoperative diagnosis and evaluation of Chinese older patients with hilar cholangiocarcinoma. BMC Geriatr 2018;18:150. [PMID: 29976141 DOI: 10.1186/s12877-018-0846-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Cui P, Pang Q, Wang Y, Qian Z, Hu X, Wang W, Li Z, Zhou L, Man Z, Yang S, Jin H, Liu H. Nutritional prognostic scores in patients with hilar cholangiocarcinoma treated by percutaneous transhepatic biliary stenting combined with 125I seed intracavitary irradiation: A retrospective observational study. Medicine (Baltimore). 2018;97:e11000. [PMID: 29851859 DOI: 10.1097/md.0000000000011000] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
26 Pinotti E, Sandini M, Famularo S, Tamini N, Romano F, Gianotti L. Resection of the caudate lobe for the treatment of hilar cholangiocarcinoma. Minerva Chir 2019;74:348-58. [PMID: 29658674 DOI: 10.23736/S0026-4733.18.07498-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Liu F, Ma WJ, Hu HJ, Regmi P, Wang JK, Li FY. The puzzle and challenge in the treatment of an intraoperative margin-positive proximal bile duct in hilar cholangiocarcinoma. Hepatobiliary Surg Nutr 2017;6:411-3. [PMID: 29312978 DOI: 10.21037/hbsn.2017.11.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Li B, Xiong XZ, Zhou Y, Wu SJ, You Z, Lu J, Cheng NS. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma. World J Gastroenterol 2017; 23(36): 6685-6693 [PMID: 29085213 DOI: 10.3748/wjg.v23.i36.6685] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
29 Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM, Datta J. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2017;24:3926-3933. [PMID: 28952140 DOI: 10.1245/s10434-017-6095-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
30 Andert A, Bruners P, Heidenhain C, Ulmer F, Klink CD, Alizai PH, Kuhl C, Neumann UP, Binnebösel M. Impact of Preoperative Three-Dimensional Computed Tomography Cholangiography on Postoperative Resection Margin Status in Patients Operated due to Hilar Cholangiocarcinoma. Gastroenterol Res Pract 2017;2017:1947023. [PMID: 28900442 DOI: 10.1155/2017/1947023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
31 Papafragkakis C, Lee J. Comprehensive management of cholangiocarcinoma: Part II. Treatment. Int J Gastrointest Interv 2017;6:94-104. [DOI: 10.18528/gii1500342] [Reference Citation Analysis]
32 Ji GW, Zhu FP, Wang K, Jiao CY, Shao ZC, Li XC. Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy. J Gastrointest Surg. 2017;21:666-675. [PMID: 28168674 DOI: 10.1007/s11605-017-3377-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
33 Schoellhammer HF, Fong Y, Singh G. Extrahepatic bile duct tumors. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00051-0] [Reference Citation Analysis]
34 Ma WJ, Shrestha A, Li FY. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value? Cancer Med 2016;5:2848-9. [PMID: 27686472 DOI: 10.1002/cam4.920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg 2016; 8(6): 436-443 [PMID: 27358676 DOI: 10.4240/wjgs.v8.i6.436] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
36 Hoffmann K, Schemmer P, Büchler MW. Reply to: "Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma". Surgery 2016;159:987-8. [PMID: 26791270 DOI: 10.1016/j.surg.2015.11.023] [Reference Citation Analysis]
37 Shen P, Fino N, Levine EA, Eversole P, Clark C. Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes. HPB (Oxford) 2015;17:1066-73. [PMID: 26373784 DOI: 10.1111/hpb.12484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]